Tag: PAA
PharmAust readies to upscale its flagship cancer drug candidate Monepantel
Clinical-stage oncology company PharmAust (ASX: PAA) could be set to upscale development of its flagship drug candidate ‘Monepantel’, a cancer drug that is potentially both applicable to humans as wel...
PharmAust targets unique market for treating cancer in dogs
Australian vets and dog-lovers could soon have an additional weapon in their toolkit to treat cancer in dogs, courtesy of a novel therapy to be developed by oncology company PharmAust’s (ASX: PAA) who...
PharmAust secures US patent for cancer drugs
PharmAust (ASX: PAA) has locked in a US patent for its aminoacetonitrile compound drug portfolio, which have anti-cancer properties.
“Allowance of this patent secures PharmAust’s ownership for over...